ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,685,044 | -1.1% | 25,090 | -0.3% | 0.04% | +6.1% |
| Q2 2023 | $1,703,922 | -11.2% | 25,165 | -29.0% | 0.03% | -13.2% |
| Q1 2023 | $1,918,224 | -9.5% | 35,457 | 0.0% | 0.04% | -11.6% |
| Q4 2022 | $2,120,683 | +29.7% | 35,457 | -1.9% | 0.04% | +22.9% |
| Q3 2022 | $1,635,000 | -66.2% | 36,157 | -58.1% | 0.04% | -63.9% |
| Q2 2022 | $4,836,000 | -25.7% | 86,287 | -5.7% | 0.10% | -9.3% |
| Q1 2022 | $6,508,000 | -3.4% | 91,527 | -11.4% | 0.11% | +5.9% |
| Q4 2021 | $6,738,000 | -28.6% | 103,249 | -17.9% | 0.10% | -30.3% |
| Q3 2021 | $9,439,000 | -9.0% | 125,787 | -5.4% | 0.14% | -7.1% |
| Q2 2021 | $10,377,000 | -5.4% | 132,982 | -0.8% | 0.16% | -11.4% |
| Q1 2021 | $10,975,000 | -7.7% | 134,002 | -6.8% | 0.18% | -12.4% |
| Q4 2020 | $11,886,000 | +18.3% | 143,745 | -7.0% | 0.20% | +2.0% |
| Q3 2020 | $10,046,000 | – | 154,600 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |